Golgi signalling proteins GOLPH3, MYO18A, PITPNC1 and RAB1B: implications in prognosis and survival outcomes of AML patients

References

• Ashlin, T.G., Blunsom, N.J., and Cockcroft, S., 2021. Courier service for phosphatidylinositol: PITPs deliver on demand. Biochimica et biophysica Acta - molecular and cell biology of lipids, 1866 (9), 158985.
   PubMed Web of Science ®Google Scholar
• Bui, S., et al., 2021. Adaptation of the Golgi apparatus in cancer cell invasion and metastasis. Frontiers in cell and developmental biology, 9. https://doi.org/10.3389/fcell.2021.806482
   PubMed Web of Science ®Google Scholar
• Buschman, M.D. and Field, S.J., 2018. MYO18A: An unusual myosin. Advances in biological regulation, 67, 84–92.
   PubMedGoogle Scholar
• Caviere, V.A., et al., 2020. Human Golgi phosphoprotein 3 is an effector of RAB1A and RAB1B. PLoS one, 15 (8), e0237514.
   Web of Science ®Google Scholar
• Choi, W., Kang, S., and Kim, J., 2022. New insights into the role of the Golgi apparatus in the pathogenesis and therapeutics of human diseases. Archives of pharmacal research, 45 (10), 671–692.
   PubMed Web of Science ®Google Scholar
• Cohen, J., 1988. The t-test for means. In: J. Cohen, ed. Statistical power analysis for the behavioral sciences. 2nd ed., chapter 2. NY: Lawrence Erlbaum Associates, 19–74.
   Google Scholar
• Dippold, H.C., et al., 2009. GOLPH3 bridges phosphatidylinositol-4- phosphate and actomyosin to stretch and shape the Golgi to promote budding. Cell, 139 (2), 337–351.
   PubMed Web of Science ®Google Scholar
• El-Meligui, Y.M., et al., 2021. Correlation study on hla-dr and cd117 (C-kit) expressions: Its prognosis and treatment response in acute myeloid leukemia patients. Pharmacogenomics and personalized medicine, 14, 381–393.
   PubMed Web of Science ®Google Scholar
• El-Sisi, M.G., et al., 2021. Serum levels of FAK and some of its effectors in adult AML: correlation with prognostic factors and survival. Molecular and cellular biochemistry, 476 (5), 1949–1963.
   PubMed Web of Science ®Google Scholar
• Fröhling, S., et al., 2005. Genetics of myeloid malignancies: pathogenetic and clinical implications. Journal of clinical oncology, 23 (26), 6285–6295.
   PubMed Web of Science ®Google Scholar
• George, T.I. and Bajel, A., 2021. Diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms. Pathology, 53 (3), 312–327.
   PubMed Web of Science ®Google Scholar
• Grimwade, D., et al., 2001. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood: the journal of the American Society of Hematology, 98 (5), 1312–1320.
   Google Scholar
• Halberg, N., et al., 2016. PITPNC1 recruits RAB1B to the Golgi network to drive malignant secretion. Cancer cell, 29 (3), 339–353.
   PubMed Web of Science ®Google Scholar
• Hanley, J. A. and McNeil, B. J., 1983. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology, 148 (3), 839–843.
   Google Scholar
• He, X., et al., 2021. CAR T cells targeting CD13 controllably induce eradication of acute myeloid leukemia with a single domain antibody switch. Leukemia, 35 (11), 3309–3313.
   PubMed Web of Science ®Google Scholar
• Huang, A., et al., 2022. Golgi phosphoprotein 3 promotes colon cancer cell metastasis through STAT3 and Integrin α3 pathways. Frontiers in molecular biosciences, 9, 277.
   Web of Science ®Google Scholar
• Jin, H., et al., 2021. Rab GTPases: central coordinators of membrane trafficking in cancer. Frontiers in cell and developmental biology, 9. https://doi.org/10.3389/fcell.2021.648384
   Web of Science ®Google Scholar
• Kirtonia, A., et al., n.d. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.
   Google Scholar
• Kuna, R. S. and Field, S. J., 2018. GOLPH3: A Golgi phosphatidylinositol(4)phosphate effector that directs vesicle trafficking and drives cancer. Journal of lipid research, 60 (2), 269–275.
   Google Scholar
• Liu, J., et al., 2021. The role of the Golgi apparatus in disease (Review). International journal of molecular medicine, 47 (4), 38.
   Web of Science ®Google Scholar
• Liu, J., Tong, J., and Yang, H., 2022. Targeting CD33 for acute myeloid leukemia therapy. BMC cancer, 22, 1–7.
   Web of Science ®Google Scholar
• López-Cortés, R., et al., 2021. Blood-based protein biomarkers in bladder urothelial tumors. Journal of proteomics, 247. https://doi.org/10.1016/j.jprot.2021.104329
   PubMed Web of Science ®Google Scholar
• Machin, D., Campbell, M. J., Tan, S. B., and Tan, S. H. 2018. Continuous outcomes. In: D. Machin, M. J. Campbell, S. B. Tan, and S. H. Tan, eds. Sample sizes for clinical, laboratory and epidemiology studies. 4th ed., chapter 5. NJ: John Wiley & Sons Ltd, 67–77.
   Google Scholar
• Mesmin, B., Kovacs, D., and D’Angelo, G., 2019. Lipid exchange and signaling at ER–Golgi contact sites. Current opinion in cell biology, 57, 8–15.
   PubMed Web of Science ®Google Scholar
• Nahm, F.S., 2022. Receiver operating characteristic curve: overview and practical use for clinicians. Korean journal of anesthesiology, 75 (1), 25–36.
   PubMed Web of Science ®Google Scholar
• Naydenov, N.G., et al., 2021. Myosin motors: novel regulators and therapeutic targets in colorectal cancer. Cancers, 13 (4), 741.
   PubMed Web of Science ®Google Scholar
• Ni, J., et al., 2021. CD13 inhibition augments DR4-induced tumor cell death in a p-ERK1/2-independent manner. Cancer biology and medicine, 18 (2), 569–586.
   PubMed Web of Science ®Google Scholar
• Obuchowski, N.A. and Mcclish, D.K., 1997. Sample size determination for diagnostic accuracy studies involving binormal ROC curve indices. Statistics in medicine, 16 (13), 1529–1542.
   PubMed Web of Science ®Google Scholar
• Pan, L., et al., 2020. Punicalagin inhibits the viability, migration, invasion, and EMT by regulating GOLPH3 in breast cancer cells. Journal of receptor and signal transduction research, 40 (2), 173–180.
   PubMed Web of Science ®Google Scholar
• Radwan, S.M., et al., 2021. The prospective prognostic value of the immune checkpoint BTLA expression in adult acute myeloid leukemia patients. Egyptian journal of medical human genetics, 22 (1), 1–8.
   Google Scholar
• Rahajeng, J., et al., 2019. Efficient Golgi forward trafficking requires GOLPH3-driven, PI4P-dependent membrane curvature. Developmental cell, 50 (5), 573–585.e5.
   PubMed Web of Science ®Google Scholar
• Ravichandran, Y., Goud, B., and Manneville, J.B., 2020. The Golgi apparatus and cell polarity: roles of the cytoskeleton, the Golgi matrix, and Golgi membranes. Current opinion in cell biology, 62, 104–113.
   PubMed Web of Science ®Google Scholar
• Sechi, S., et al., 2017. Rab1 interacts with GOLPH3 and controls Golgi structure and contractile ring constriction during cytokinesis in Drosophila melanogaster. Open biology, 7 (1), 160257.
   PubMed Web of Science ®Google Scholar
• Sechi, S., et al., 2020. Oncogenic roles of GOLPH3 in the physiopathology of cancer. International journal of molecular sciences, 21 (3), 933.
   PubMed Web of Science ®Google Scholar
• Su, Y., et al., 2021. Clinical and prognostic significance of CD117 in non-small cell lung cancer: a systemic meta-analysis. Pathobiology, 88 (4), 267–276.
   PubMed Web of Science ®Google Scholar
• Taft, M.H., et al., 2013. Functional characterization of human myosin-18A and its interaction with F-actin and GOLPH3. The journal of biological chemistry, 288 (42), 30029–30041.
   PubMed Web of Science ®Google Scholar
• Vosberg, S. and Greif, P.A., 2019. Clonal evolution of acute myeloid leukemia from diagnosis to relapse. Genes, chromosomes and cancer, 58 (12), 839–849.
   PubMed Web of Science ®Google Scholar
• Wang, C.X., et al., 2021. Golgi phosphoprotein 3 represents a novel tumor marker for gastric and colorectal cancers. Disease markers, 2021. https://doi.org/10.1155/2021/8880282
   Web of Science ®Google Scholar
• Waugh, M.G., 2019. The Great Escape: how phosphatidylinositol 4-kinases and PI4P promote vesicle exit from the Golgi (and drive cancer). Biochemical journal, 476 (16), 2321–2346.
   PubMedGoogle Scholar
• Yang, J., et al., 2013. SF3B1 mutation is a rare event in Chinese patients with acute and chronic myeloid leukemia. Clinical biochemistry, 46 (7-8), 701–703.
   PubMed Web of Science ®Google Scholar
• Zhao, C., et al., 2020. Golph3 promotes angiogenesis of lung adenocarcinoma by regulating the wnt/β-catenin signaling pathway. OncoTargets and therapy, 13, 6265–6277.
   PubMed Web of Science ®Google Scholar
• Zheng, X.C., et al., 2020. Protosappanin B exerts anti-tumor effects on colon cancer cells via inhibiting GOLPH3 expression. Integrative cancer therapies, 19, 1–10.
   Web of Science ®Google Scholar